4.4 Article

Altered Cytochrome P450 Expression in Mice during Pregnancy

Journal

DRUG METABOLISM AND DISPOSITION
Volume 39, Issue 2, Pages 165-169

Publisher

AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
DOI: 10.1124/dmd.110.035790

Keywords

-

Funding

  1. National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD055313, K12-HD055892]
  2. National Institutes of Health National Center for Research Resources [UL1-RR029879]

Ask authors/readers for more resources

Human pregnancy is known to influence hepatic drug metabolism in a cytochrome (P450)-specific manner. However, the underlying mechanisms remain unknown, in part due to a lack of experimental models to study altered drug metabolism during pregnancy. In this study, we examined how pregnancy influences expression of major P450 isoforms in mice. Liver tissues were isolated from female FVB/N-mice at different gestational time points: prepregnancy, 7, 14, and 21 days of pregnancy, and 7 days postpartum. mRNA expression levels of major P450 isoforms (Cyp1a2, Cyp2a5, Cyp2b10, Cyp2c37, Cyp2d22, Cyp2e1, Cyp3a11, and Cyp3a41) in the liver tissues were determined by quantitative real-time polymerase chain reaction. Whereas Cyp2a5 expression was unchanged, Cyp3a41 expression was significantly increased during pregnancy. In contrast, expression of Cyp1a2, Cyp2c37, Cyp2d22, Cyp2e1, and Cyp3a11 was decreased. Expression of Cyp2d22 and Cyp2e1 isoforms correlated with that of peroxisome proliferator-activated receptor (PPAR)alpha in the mouse livers, suggesting potential involvement of PPAR alpha in down-regulation of the P450 expression during pregnancy. Effects of pregnancy on expression of other P450 mouse isoforms as well as on in vivo drug disposition remain to be characterized. These results provide a guide for future studies on P450 regulation during pregnancy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Rheumatology

Impact of Antimalarial Adherence on Mortality Among Patients With Newly Diagnosed Systemic Lupus Erythematosus: A Population-Based Cohort Study

M. Rashedul Hoque, J. Antonio Avina-Zubieta, Mary A. De Vera, Yi Qian, John M. Esdaile, Hui Xie

Summary: Adherence to antimalarial therapy is significantly associated with a lower risk of premature mortality among patients with incident systemic lupus erythematosus (SLE).

ARTHRITIS CARE & RESEARCH (2022)

Article Rheumatology

Has the incidence of total joint arthroplasty in rheumatoid arthritis decreased in the era of biologics use? A population-based cohort study

Vivienne Y. Zhou, Diane Lacaille, Na Lu, Jacek Kopec, Don Garbuz, Yi Qian, J. Antonio Avina-Zubieta, John Esdaile, Hui Xie

Summary: The study found that the introduction of biological DMARDs was associated with a significant reduction in total hip and knee arthroplasty incidences among patients with rheumatoid arthritis, but not among patients with osteoarthritis.

RHEUMATOLOGY (2022)

Review Pharmacology & Pharmacy

RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies

Gavin M. Traber, Ai-Ming Yu

Summary: RNA interference (RNAi) is a versatile method for regulating gene expression. Endogenous microRNAs (miRNAs) and exogenous small interfering RNAs (siRNAs) form RNA-induced silencing complexes to achieve gene regulation. RNAi-based drugs have been approved for clinical use and advancements in technology aim to improve their efficacy and safety. Chemical modifications and delivery platforms are being explored to enhance the structure, stability, and activity of RNA molecules. Novel biologic RNAi agents are also being developed for research purposes.

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2023)

Article Rheumatology

Risk of Arrhythmia Among New Users of Hydroxychloroquine in Rheumatoid Arthritis and Systemic Lupus Erythematosus: A Population-Based Study

M. Rashedul Hoque, Leo Lu, Narsis Daftarian, John M. Esdaile, Hui Xie, J. Antonio Avina-Zubieta

Summary: This study assessed the association between hydroxychloroquine (HCQ) initiation and the risk of arrhythmia among patients with new-onset rheumatoid arthritis or new-onset systemic lupus erythematosus. The results showed that the risk of arrhythmia was not increased among new users of HCQ.

ARTHRITIS & RHEUMATOLOGY (2023)

Article Rheumatology

Investigating Associations Between Access to Rheumatology Care, Treatment, Continuous Care, and Healthcare Utilization and Costs Among Older Individuals With Rheumatoid Arthritis

Claire E. H. Barber, Diane Lacaille, Ruth Croxford, Cheryl Barnabe, Deborah A. Marshall, Michal Abrahamowicz, Hui Xie, J. Antonio Avina-Zubieta, John M. Esdaile, Glen S. Hazlewood, Peter Faris, Steven Katz, Paul MacMullan, Dianne Mosher, Jessica Widdifield

Summary: This study examines the association between rheumatologist access, early treatment, and ongoing care of older-onset rheumatoid arthritis (RA) and healthcare utilization and costs following diagnosis. The results show that access to rheumatologists, timely treatment, and ongoing care are associated with lower total healthcare costs at 5 years. Investments in improving access to care may lead to long-term health system savings.

JOURNAL OF RHEUMATOLOGY (2023)

Review Pharmacology & Pharmacy

50th Anniversary Celebration Collection Special Section on Perspective on Drug Metabolism and Disposition, Part I-Minireview Recombinant Technologies Facilitate Drug Metabolism, Pharmacokinetics, and General Biomedical Research

Joseph M. Cronin, Ai -Ming Yu

Summary: The development of medications requires a thorough understanding of their pharmacokinetic and pharmacodynamic properties. The study of ADME gene products and their functions has been revolutionized by recombinant DNA technologies. These technologies enable the investigation of drug metabolism and disposition, as well as the study of posttranscriptional regulation of ADME genes.

DRUG METABOLISM AND DISPOSITION (2023)

Article Rheumatology

Risk of severe infections after the introduction of biologic DMARDs in people with newly diagnosed rheumatoid arthritis: a population-based interrupted time-series analysis

Vivienne Y. Zhou, Diane Lacaille, Na Lu, Jacek A. Kopec, Yi Qian, Bohdan Nosyk, J. Antonio Avina-Zubieta, John M. Esdaile, Hui Xie

Summary: This population-based retrospective cohort study aimed to determine the impact of biologic DMARDs (bDMARDs) introduction on severe infections among newly diagnosed RA patients compared with non-RA individuals. Results showed that the risk of severe infections significantly increased in RA patients after the introduction of bDMARDs.

RHEUMATOLOGY (2023)

Letter Rheumatology

Risk of arrhythmia among new users of hydroxychloroquine: comment on the article by Hoque et al Reply

M. Rashedul Hoque, Hui Xie, Diane Lacaille, John M. Esdaile, J. Antonio Avina-Zubieta

ARTHRITIS & RHEUMATOLOGY (2023)

Article Rheumatology

Impact of Loneliness and Social Isolation on Mental Health Outcomes Among Individuals With Rheumatic Diseases During the COVID-19 Pandemic

Alyssa Howren, J. Antonio Avina-Zubieta, Joseph H. Puyat, Deborah Da Costa, Hui Xie, Eileen Davidson, Nevena Rebic, Louise Gastonguay, Hallie Dau, Mary A. De Vera

Summary: The objective of this study was to assess the mental and social health outcomes of individuals with rheumatic disease during the COVID-19 pandemic, and to evaluate the relationship between loneliness and social isolation with depression and anxiety. An international online survey was conducted, and the results showed significant associations between loneliness and social isolation with depression and anxiety.

ACR OPEN RHEUMATOLOGY (2023)

Article Pharmacology & Pharmacy

Use of recombinant microRNAs as antimetabolites to inhibit human non-small cell lung cancer

Yixin Chen, Mei-Juan Tu, Fangwei Han, Zhenzhen Liu, Neelu Batra, Primo N. Lara, Hong -Wu Chen, Huichang Bi, Ai -Ming Yu

Summary: The research found that miR-22-3p, miR-9-5p, and miR-218-5p are antiproliferative miRNAs targeting non-small cell lung cancer (NSCLC) cells, and they inhibit folate metabolism and alter amino acid metabolism in NSCLC cells. In addition, the inhibition of glucose uptake by miR-22-3p and the reduction of serine biosynthesis from glucose by miR-9-5p and -218-5p were also confirmed. Recombinant miR-22-3p was more effective than miR-9-5p and -218-5p in inhibiting NSCLC cell respiration, glycolysis, and colony formation, without causing any toxicity.

ACTA PHARMACEUTICA SINICA B (2023)

Article Health Care Sciences & Services

Evaluating the Effectiveness of a Codeveloped e-Mental Health Intervention for University Students: Protocol for a Randomized Controlled Trial

Angel Y. Wang, Melissa Vereschagin, Chris G. Richardson, Hui Xie, Kristen L. Hudec, Richard J. Munthali, Lonna Munro, Calista Leung, Ronald C. Kessler, Daniel V. Vigo, Lic Psych

Summary: This paper describes a randomized controlled trial (RCT) protocol that aims to assess the effectiveness of the Minder app in improving the mental health and substance use outcomes of university students. The study will recruit 1496 university students and randomize them into an intervention group and a control group. The primary outcomes include changes in anxiety symptomology, depressive symptomology, and alcohol consumption risk. The trial is expected to be completed by June 2023.

JMIR RESEARCH PROTOCOLS (2023)

Article Rheumatology

Effect of Immunosuppressive or Immunomodulatory Agents on Severe COVID-19 Outcomes: A Population-Based Cohort Study

Shelby Marozoff, Jeremiah Tan, Na Lu, Ayesha Kirmani, Jonathan M. Loree, Hui Xie, Diane Lacaille, Jacek A. Kopec, John M. Esdaile, Bonnie Corradetti, Peter Malone, Cheryl L. Koehn, Philippa Mennell, Alison M. Hoens, J. Antonio Avina-Zubieta

Summary: This population-based cohort study investigated the association between the use of immunosuppressive and immunomodulatory agents (IIAs) and severe COVID-19 outcomes. The study found that the current use of MMF and glucocorticoids was associated with an increased risk of severe COVID-19 outcomes compared to non-use of these agents.

ACR OPEN RHEUMATOLOGY (2023)

Article Psychology, Multidisciplinary

Tutorial: Assessing the Impact of Nonignorable Missingness on Regression Analysis Using Index of Local Sensitivity to Nonignorability

Bocheng Jing, Yi Qian, Daniel F. Heitjan, Hui Xie

Summary: This article introduces a sensitivity analysis method based on a measure of robustness, which can be used to evaluate the credibility of MAR analysis in psychology research. The method is straightforward to use and avoids the estimation of complicated non-MAR missing-data models.

PSYCHOLOGICAL METHODS (2023)

Article Rheumatology

A Population-Based Study Evaluating Retention in Rheumatology Care Among Patients With Rheumatoid Arthritis

Claire E. H. Barber, Diane Lacaille, Ruth Croxford, Cheryl Barnabe, Deborah A. Marshall, Michal Abrahamowicz, Hui Xie, J. Antonio Avina-Zubieta, John M. Esdaile, Glen Hazlewood, Peter Faris, Steven Katz, Paul MacMullan, Dianne Mosher, Jessica Widdifield

Summary: This study assessed adherence to system-level performance measures in rheumatology care for patients with rheumatoid arthritis (RA). The results showed a decline in the percentage of patients with annual visits over time. Factors such as age, gender, and healthcare resources were found to affect the likelihood of receiving ongoing rheumatology care.

ACR OPEN RHEUMATOLOGY (2022)

Article Oncology

Impact of 18-Month Soy Protein Supplementation on Steroid Hormones and Serum Biomarkers of Angiogenesis, Apoptosis, and the Growth Hormone/IGF-1 Axis: Results of a Randomized, Placebo-Controlled Trial in Males Following Prostatectomy

Maarten C. Bosland, Jonathan Huang, Michael J. Schlicht, Erika Enk, Hui Xie, Ikuko Kato

Summary: The study found that 18 months of soy protein isolate supplementation reduced circulating testosterone and SHBG levels in males, but the effects on other cancer biomarkers require further investigation.

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2022)

No Data Available